ROSSI, GUIDO
 Distribuzione geografica
Continente #
NA - Nord America 1.455
EU - Europa 811
AS - Asia 187
AF - Africa 17
SA - Sud America 2
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 2.474
Nazione #
US - Stati Uniti d'America 1.427
UA - Ucraina 273
CN - Cina 151
IT - Italia 131
FI - Finlandia 89
DE - Germania 81
SE - Svezia 81
IE - Irlanda 56
NL - Olanda 56
CA - Canada 27
GB - Regno Unito 27
IN - India 22
CI - Costa d'Avorio 17
BG - Bulgaria 12
TW - Taiwan 6
KR - Corea 3
FR - Francia 2
HU - Ungheria 2
ID - Indonesia 2
PE - Perù 2
SG - Singapore 2
AU - Australia 1
EU - Europa 1
LU - Lussemburgo 1
MX - Messico 1
TR - Turchia 1
Totale 2.474
Città #
Jacksonville 288
Chandler 276
Princeton 90
Millbury 76
Boston 64
Amsterdam 56
Ashburn 48
Houston 47
Nanjing 44
Wilmington 41
Woodbridge 35
Beijing 29
Napoli 29
Ottawa 24
Norwalk 23
Naples 22
Pune 22
Kronberg 19
Nanchang 19
Ann Arbor 14
Tianjin 14
Shenyang 13
Cagliari 12
Sofia 12
Hebei 10
Boardman 9
Jiaxing 9
Orange 8
Kunming 6
Falls Church 5
New York 5
Taipei 4
Florence 3
Gangnam-gu 3
Giugliano In Campania 3
Rome 3
Salerno 3
Augusta 2
Changsha 2
Des Moines 2
Dublin 2
Lanzhou 2
Lima 2
New Taipei 2
Piemonte 2
Redmond 2
Rocca Canavese 2
Romainville 2
Tappahannock 2
Torre Annunziata 2
Adelaide 1
Ajax 1
Cambridge 1
Duncan 1
Edinburgh 1
Edmonton 1
Fuzhou 1
Genova 1
Giaveno 1
Henderson 1
Indiana 1
Lanuvio 1
Luxembourg 1
Meta 1
Mexico City 1
Monmouth Junction 1
Pavia 1
Portici 1
Riva Del Garda 1
San Francisco 1
San Remo 1
Seattle 1
Simi Valley 1
Taizhou 1
Toronto 1
Venezia 1
Vicenza 1
Walnut 1
Washington 1
Yellow Springs 1
Totale 1.444
Nome #
Combined analysis of galectin-3 and BRAFV600E improves the accuracy of fine-needle aspiration biopsy with cytological findings suspicious for papillary thyroid carcinoma. 55
Calmodulin-dependent kinase IV links toll-like receptor 4 signaling with survival pathway of activated denditric cells 52
67 kDa Laminin Receptor (67LR) Involvement in the Trafficking of Normal and Leukemic Hematopoietic Stem Cells; Computer-Aided Identification of a Small Inhibitory Molecule 52
The metastasis-associated 67 kDa laminin receptor is involved in G-CSF-induced hematopoietic stem cell mobilization. 48
Are RET/PTC rearrangements in benign thyroid nodules of biological significance? 47
Cleavage of urokinase receptor regulates its interaction with integrins in thyroid cells. 44
Urokinase-mediated post-transcriptional regulation of urokinase-receptor expression in non small cell lung carcinoma. 43
Calmodulin-Dependent Kinase II Mediates Vascular Smooth Muscle Cell Proliferation and Is Potentiated by Extracellular Signal Regulated Kinase 43
FN-induced proliferation in thyroid cells is mediated by {alpha}v{beta}3 integrin through Ras/Raf-1/Mek/Erk and calcium/CaMKII signals. 42
Growing thyroid nodules with benign histology and RET rearrangement. 42
Expression of the 67-kDa laminin receptor in acute myeloid leukemia cells mediates adhesion to laminin and is frequently associated with monocytic differentiation. 40
ANLYSIS OF TUMOR ANTIGEN EXPRESSION IN SPORADIC MEDULLARY THYROID CARCINOMA: EXPRESSION OF NY-ESO-1 40
Nino Salvatore tenth anniversary memorial meeting:thyroid and beyond 40
Laminin receptors in differentiated thyroid tumors: restricted expression of the 67-Kilodalton laminin receptor in follicular carcinoma cells. 39
HIGH EXPRESSION AND IMMUNE RESPONSE TO NY-ESO-1 ANTIGEN IN MEDULLARY THYROID CARCINOMA 39
CaMKII regulates insulin-mediated cell proliferation and glucose uptake in skeletal muscle cells through Erk 1/2 activation 39
The integrin alpha V Beta 3 promotes thyroid cell proliferation through the calcium/calmodulin-dependent protein kinase II and ERK pathways 38
Amiodarone induces apoptosis in thyroid and non thyroid cells through a iodine-independent mechanism. 37
Insulin stimulates fibroblast proliferation through calcium-calmodulin-dependent kinase II 37
Cell to cell contact modulates the expression of the beta1 family of integrins in primary cultures of thyroid cells 36
Urokinase-type plaminogen activator up-regulates the expression of its cellular receptor through a post-transcriptional mechanism 36
Analysis of cancer/testis antigens in sporadic medullary thyroid carcinoma: expression and humoral response to NY-ESO-1 35
A sandwich enzyme immune assay for wheat gliadin 35
Soluble and cleaved forms of the urokinase-receptor: degradation products or active molecules? 35
The crosstalk between Dendritic and Natural Killer cells together with the function of Tumor Associated Macrophages (TAM) represent novel cancer-related targets for Human Immunodeficiency Type-1 Protease Inhibitors. 35
Differential expression and cytoplasm/membrane distribution of endoglin (CD105) in human tumour cell lines: Implication in the modulation of cell proliferation 34
Pendrin is a Novel In Vivo Downstream Target Gene of the TTF-1/Nkx-2.1 Homeodomain Transcription Factor in Differentiated Thyroid Cells 34
Detection of RET/PTC, TRK and BRAF mutations in preoperative diagnosis of thyroid nodules with indeterminate cytological findings 33
Differential expression of a truncated form of the urokinase-type plasminogen-activator receptor in normal and tumor thyroid cells. 33
Urokinase-type plasminogen-activator up regulates the expression of its cellular receptor 32
Regulation of the expression of the low-affinity IgE receptor (FceRII) in the human monocyte-like cell line U-937 by phorbol esters and IgE. 31
The cleavage of the urokinase receptor regulates its multiple functions. 31
Thiroglobulin production by rat thyroid cells in culture. A study at the level of single cells 31
Sandblasted-acid-etched titanium surface influences in vitro the biological behavior of SaOS-2 human osteoblast-like cells 31
Integrin-dependent cell growth and survival are mediated by different signals in thyroid cells. 29
Calcium/Calmodulin-dependent Protein Kinase II binds to Raf-1 and modulates Integrin-stimulated ERK activation. 29
Fibronectin is required to prevent thyroid cell apoptosis through an integrin-mediated adhesion mechanism. 28
Somatostatin inhibits PC C13 thyroid cell proliferation through the modulation of phosphotyrosine phosphatase activity: impairment of somatostatinergic effect by stable expression of E1A oncogene 28
Preparative isolation of the cell receptor for Immunoglobulin E 28
Role of the 67 kDa laminin receptor in the trafficking of normal and leukemic cells 28
Calcium/calmodulin–dependent kinase IV regulates cell proliferation in undifferentiated carcinomas 28
Ruolo della chinasi calcio-calmodulina dipendente tipo II nel segnale di RET/PTC e delle chemochine 28
Calcium-calmodulin-dependent kinase II (CaMKII) mediates insulin-stimulated proliferation and glucose uptake. 28
Characterization and properties of thyroid iodoproteins from severely iodine deficient rats 27
Activation and role of Calcium/calmodulin–dependent kinase II in thyroid carcinomas 27
The plasminogen activator system in fibroblasts from systemic sclerosis. 27
Combined analysis of galectin-3 and BRAFV600E improves the accuracy of fine-needle aspiration biopsy with cytological findings suspicious for papillary thyroid carcinoma. 27
Bioethics and arts: an Italian experience 27
Assay and partial characterization of the solubilized cell surface receptor for Immunoglobulin E 25
Calcium/calmodulin–dependent kinase II (CaMKII) is constitutively activated in Thyroid carcinomas 25
Role of the Urokinase Receptor (uPaR) in the cross-talk of hematopoietic Stem Cells with the bone marrow environment 25
Urokinase-type plasminogen activator/type-2 plasminogen activator inhibitor complexes are not internalized upon binding to the urokinase-type plasminogen activator receptor in THP-1 cells 24
Production of urokinase-type plasminogewn activator by normal and transformed rat thyroid cells in culture 23
Reconstitution of the receptor for Immunoglobulin E into liposomes. Reincorporation of purified receptors 23
Isolation of antibody-forming cells by using cluster formation in combination with velocity sedimentation 23
X-ray crystallographic studies of the Fab Fragment from two human myeloma proteins 23
Role of different dialysis membranes in the release of Interleukin-6-soluble receptor in uremic patients 23
Urokinase-type plasminogen-activator receptor associates to a cell surface molecule in monocytic cells. 23
ESPRESSIONE DI CANCER TESTIS ANTIGENS NEL CARCINOMA MIDOLLARE SPORADICO DELLA TIROIDE: ESPRESSIONE DI NY-ESO-1 E RISPOSTA ANTICORPALE 23
Calcium/calmodulin-dependent protein kinase II binds to Raf-1 and modulatesintegrin-stimulated ERK activation. 23
Fluorescence and circular dichroism of Bence-Jones proteins at high temperature 22
Retinoic acid induces intercellular adhesion molecule-1 hyperexpression in human thyroid carcinoma cell line 22
Caratterizzazione dell'espressione e della funzione di CaMKIV in cellule tiroidee. 22
The effect of X-irradiation on the appearance of antibody forming cells in the mouse spleen following the injection of sheep erythrocytes 21
Loss of polarity and the novo expression of the beta1 family of integrins in thyroid tumors 21
Regulation of the expression of the low affinity IgE receptor (FCepsilonRII) in the human monocyte-like cell line U937 by phorbol esters and IgE 21
Crystallization of Fragment Fab of human IgG myeloma proteins 21
Patologia Generale 21
Patologia Generale 21
Detection of BRAF mutation in thyroid papillary carcinomas by mutant allele-specific PCR amplification (MASA). 21
Serum withdrawal-induced apoptosis in thyroid cells is caused by loss of fibronectin-integrin interaction. 20
Lovastatin-induced apoptosis in thyroid cells: involvement of cytochrome c and lamin B. 20
The receptor for the plasminogen activator of urokinase-type is up-regulated in transformed rat thyroid cells 20
Iodide excess induces apoptosis in thyroid cells through a p53-independent mechanism involving oxidative stress. 20
Crystals of fragment Fab'; preparation from pepsin digests of human myeloma proteins 20
Intercellular Adhesion Molecule 1 is upregulated via the protein kinase C pathway in human thyroid carcinoma cell lines 20
Differential expression of a truncated form of the urokinase-type Plasminogen activator receptor in normal and tumor thyroid cells. 20
Interaction of promonocytic U937 cells with proteins of the extracellular matrix. 19
Post-transcriptional regulation of gene expression in the plasminogen activation system 19
Crystallographic data for the Fab Fragment of a human myeloma Immunoglobulin 19
Effect of Dystamycin A on the immune response in vitro against sheep red blood cells 19
Interactions of promonocytic U937 cells with proteins of the extracellular matrix 18
Expression of GM-CSF receptor and in vitro effects of GM-CSF on human fibroblasts 18
The urokinase/urokinase receptor: a novel target for the treatment of allergic diseases 18
The different cardiac expression of the Type 2 Iodothyronine deiodinase gene between human and rat is related to the differential response of the dio2 genes to NKX-2.5 and GATA-4 transcription factors 16
Urokinase-type plasminogen-activator and normal thyroid cell adhesion to the extracellular matrix 15
Involvement of the urokinase-type plasminogen activator receptor in hematopoietic stem cell mobilization. 12
Expression of GM-CSF receptor and "in vitro" effects of GM-CSF on human fibroblasts 12
revalence of RET/PTC rearrangement in benign and malignant thyroid nodules and its clinical application. 11
N6-isopentiladenosine induces apoptosis in thyroid cells 10
Totale 2.550
Categoria #
all - tutte 9.981
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.981


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20198 0 0 0 0 0 0 0 0 0 0 1 7
2019/2020322 91 2 54 3 57 0 0 2 0 6 40 67
2020/2021483 3 55 61 59 60 61 57 1 61 5 60 0
2021/2022505 15 0 0 6 12 18 22 13 62 36 141 180
2022/2023588 98 73 11 43 68 67 0 56 81 59 26 6
2023/2024246 13 54 32 12 14 55 2 56 4 4 0 0
Totale 2.550